Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

First use of alemtuzumab in Balo's concentric sclerosis: a case report.
Metabolic features of the cell danger response.
Apitope Announces Completion of Enrolment in Phase IIA Clinical Trial of ATX-MS-1467 in Relapsing Multiple Sclerosis
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
Efficacy and safety of Privigen(®) in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study).
Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.
Flow cytometric analysis of cerebrospinal fluid samples and its usefulness in routine clinical practice.
Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis.
A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients.
Opposing Effects of Membrane-Anchored CX3CL1 on Amyloid and Tau Pathologies via the p38 MAPK Pathway.
T cells become licensed in the lung to enter the central nervous system.
Mechanism of action, pharmacokinetics, adverse effects, and therapeutic uses of amiloride hydrochloride, a new potassium-sparing diuretic.
Neuromyelitis optica.
CHMP assessment report for Sovrima (International nonproprietary name: idebenone)
Genzyme’s Lemtrada Approved in Argentina for Treatment of Multiple Sclerosis
Diffuse and heterogeneous T2-hyperintense lesions in the splenium are characteristic of neuromyelitis optica.
Tumefactive multiple sclerosis requiring emergent biopsy and histological investigation to confirm the diagnosis: a case report.
SMC Says Yes to Lemtrada(R)a- 1/4 (alemtuzumab) 12mg IV, a New Treatment for Adults with Active Relapsing Remitting-Multiple Sclerosis (RRMS)
Evaluation of an electronic diary for improvement of adherence to interferon beta-1b in patients with multiple sclerosis: design and baseline results of an observational cohort study.
Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis - a review.
Dispositional optimism is unidimensional or bidimensional? The Portuguese revised Life Orientation Test.
Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy.
FDA warns about seizures linked to MS drug
Pilates based core stability training in ambulant individuals with multiple sclerosis: Protocol for a multi-centre randomised controlled trial.
Alpha4-integrin antagonism--an effective approach for the treatment of inflammatory diseases?

Pages